3E043GCIntroduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach
- Billable / Specific Code
3E043GC is a billable ICD-10-PCS procedure code for Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Operation | 0 | Introduction |
| 4 | BodySystem/Region | 4 | Central Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | G | Other Therapeutic Substance |
| 7 | Qualifier | C | Other Substance |
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for 3E043GC under the General Equivalence Mappings.
Code History
- XW04306 — Introduce Brexanolone in Central Vein, Perc, New Tech 6
- XW04308 — Introduce Spesolimab in Central Vein, Perc, New Tech 8
- XW04326 — Introduce Nerinitide in Central Vein, Perc, New Tech 6
- XW0433A — Introduce Bentracimab in Central Vein, Perc, New Tech 10
- XW04357 — Introduce Narsoplimab in Central Vein, Perc, New Tech 7
- XW04367 — Introduce Terlipressin in Central Vein, Perc, New Tech 7
- XW04372 — Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
- XW04377 — Introduce Trilaciclib in Central Vein, Perc, New Tech 7
- XW04388 — Introduce Treosulfan in Central Vein, Perc, New Tech 8
- XW04392 — Introduce Defibrotide in Central Vein, Perc, New Tech 2
- XW04398 — Introduce Inebilizumab in Central Vein, Perc, New Tech 8
- XW043A3 — Introduce Bezlotoxumab in Central Vein, Perc, New Tech 3
- XW043BA — Introduce Orca-T Allo in Central Vein, Perc, New Tech 10
- XW043C6 — Introduce Eculizumab in Central Vein, Perc, New Tech 6
- XW043F3 — Introduce New Tech Therap in Central Vein, Perc, New Tech 3
- XW043F5 — Introduce New Tech Therap in Central Vein, Perc, New Tech 5
- XW043FA — Introduce Non-CAR-T Ther in Central Vein, Perc, New Tech 10
- XW043FB — Introduce Valoct Roxaparv in Central Vein, Perc, New Tech 1
- XW043G5 — Introduce Sarilumab in Central Vein, Perc, New Tech 5
- XW043G7 — Introduce Allogen CAR T in Central Vein, Perc, New Tech 7
- XW043H5 — Introduce Tocilizumab in Central Vein, Perc, New Tech 5
- XW043L7 — Introduce Lifileucel in Central Vein, Perc, New Tech 7
- XW043QB — Introduce Iloprost in Central Vein, Perc, New Tech 11
- XW043W5 — Introduce Caplacizumab in Central Vein, Perc, New Tech 5
Similar Procedure Codes
Questions About 3E043GC
Is 3E043GC a billable code?
Yes. 3E043GC is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in 3E043GC mean?
3E043GC breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 4 is the BodySystem/Region (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character G is the Substance (Other Therapeutic Substance); the 7th character C is the Qualifier (Other Substance).
What is the ICD-9-PCS equivalent of 3E043GC?
Under the General Equivalence Mappings, Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach crosswalks to ICD-9-PCS 99.08. The mapping is approximate, so confirm it fits the documentation.
